Abstract
Introduction: As with any bioprosthetic valve, bioprosthetic valves in the pulmonary position have a finite life span and patients with bioprosthetic pulmonary valves require lifetime management to treat valve dysfunction. Areas covered: In this article, authors discuss the current medical management for the treatment of dysfunctional bioprosthetic valves. This review is based on both an extensive review of the recent cardiac surgical/interventional cardiology literature (PubMed and MEDLINE database searches from 1958 to 2019) and personal experience. Expert opinion: Valve technology is rapidly progressing and with a coordinated effort from cardiac surgeons and interventional cardiologists, patients suffering from bioprosthetic pulmonary valve dysfunction can expect to have a decreased number of procedures and less invasive procedures over their lifetime now.
Original language | English (US) |
---|---|
Pages (from-to) | 7-16 |
Number of pages | 10 |
Journal | Expert review of cardiovascular therapy |
Volume | 18 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2 2020 |
Bibliographical note
Publisher Copyright:© 2020, © 2020 Informa UK Limited, trading as Taylor & Francis Group.
Keywords
- Bioprosthetic
- intentional frame fracture
- pulmonary valve
- surgical bioprosthetic pulmonary valve placement
- transcatheter pulmonary valve
PubMed: MeSH publication types
- Journal Article
- Review